Found 5 matching trials
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML PHASE2 This is a multicenter, open-label study in people aged 18 and older with re...
Show More Location
Multiple Locations
Learn More & Join Trial
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL PHASE1 This study is being done to determine the safety, efficacy and tolerability...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia PHASE3 The primary objective of this study is to demonstrate the efficacy of Iomab...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome PHASE1 This phase I trial studies the side effects and best dose of iodine I 131mo...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma EARLY_PHASE1 This is a pilot study; patients will receive 131-I apamistamab prior to CAR...
Show More Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial